Executive Summary
An extraordinary cluster of 30 officer change 8-K filings under Item 5.02 occurred on January 22, 2026, spanning financials, biotech/healthcare, retail/consumer, and industrials, representing potential synchronized governance housekeeping or early-year board refreshes. Uniformly neutral sentiment, low average materiality (~3/10), and pervasive lack of specifics on positions, individuals, or reasons create widespread disclosure opacity, limiting immediate actionable insights but signaling portfolio-level vigilance for leadership stability. No evident market-moving events, but the volume elevates systemic governance risk across mid- and large-cap names; institutional investors should prioritize full filing reviews for alpha edges.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 20, 2026.
Investment Signals(5)
- Target Corp (TGT)↓(BULLISH)▲
Low materiality (2/10) and risk filing indicates stable retail leadership amid economic pressures
- JPMorgan Chase (JPM)(BULLISH)▲
Routine low-risk disclosure in banking bellwether reinforces operational continuity
- Deere & Co (DE)↓(BULLISH)▲
Minimal impact (2/10) officer change supports industrials resilience thesis
- Apogee Enterprises (APOG)(BEARISH)▲
Highest materiality (5/10) amid undisclosed details flags potential disruption
- Predictive Oncology Inc. (POAI)↓(BEARISH)▲
Medium risk (4/10) biotech filing with opacity warrants caution
Risk Flags(4)
Highest materiality (5/10) with no details on position or reason, amplifying uncertainty in industrials
Medium risk pharma distributor lacks succession or impact disclosure, tied to Reg FD
Officer change plus bylaws amendment without specifics heightens biotech governance concerns
- Cluster-wide/Disclosure Deficiency▼
100% of 30 filings omit key details, suggesting potential underreported instability across sectors
Opportunities(4)
- JPMorgan Chase (JPM)/Banking Stability◆
Low-risk routine change offers dip-buying in leading financial amid sector cluster
Minimal materiality enables long position if consumer recovery narrative strengthens
- Financial Sector Rotation◆
7+ filings (JPM, ACGL, FIS) signal post-change clarity for overweight vs. volatile biotech peers
- Biotech Turnaround Plays◆
Ventyx, MBX changes may precede positive appointments in undervalued small-caps
Sector Themes(3)
- Financial Services Turnover Surge(NEUTRAL TO BULLISH)◆
7+ filings (JPM, ACGL, FIS, RDN, EQBK) point to sector-wide leadership alignments, potentially regulatory-driven; monitor for M&A catalysts
- Biotech/Healthcare Flux(BEARISH TILT)◆
5 filings (MBX, Ventyx, UTHR, POAI, Cencora) reflect high-burn talent churn; implies volatility but opportunity in successors
- Retail/Consumer Refresh(BULLISH)◆
6 cases (TGT, CAL, LVLU, HAS) amid soft demand signal routine updates, low disruption risk for defensive portfolios
Watch List(4)
- Apogee Enterprises (APOG)👁
Highest materiality demands full exhibit review for governance shift details
- JPMorgan Chase (JPM)👁
Bellwether banker officer change; track for C-suite implications
Retail leader filing amid consumer slowdown; follow for succession news
- United Therapeutics (UTHR)👁
Bylaws + officer combo filing elevates structural change monitoring
Filing Analyses(30)
22-01-2026
Hasbro, Inc. disclosed an officer change event via Form 8-K filed on January 22, 2026 (AccNo: 0000046080-26-000003, Size: 541 KB), under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
22-01-2026
Shenandoah Telecommunications Co/VA/ filed an 8-K on January 22, 2026 (AccNo: 0001171843-26-000366, Size: 205 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or quantitative data are provided in the available information. Sector is not specified.
22-01-2026
Caleres Inc filed a Form 8-K on January 22, 2026 (AccNo: 0000014707-26-000006, Size: 163 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
22-01-2026
MBX Biosciences, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018700, Size: 237 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
22-01-2026
Cencora, Inc. filed a Form 8-K on 2026-01-22 (AccNo: 0001104659-26-005604, Size: 263 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.
22-01-2026
ARCH Capital Group Ltd. disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0000947484-26-000004, Size: 208 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or compensatory arrangements are provided in the available summary. Sector not specified.
22-01-2026
Digital Ally, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003195, Size: 246 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason, or compensation provided.
22-01-2026
ContextLogic Holdings Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001140361-26-001964, Size: 200 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected position, individual, reason for change, or quantitative data are disclosed in the provided filing summary. Event type is classified as Officer Change; sector not specified.
22-01-2026
Target Corp filed an 8-K on January 22, 2026 (AccNo: 0000027419-26-000002, size 145 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer(s) involved, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
22-01-2026
BrooQLy Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001477932-26-000313, Size: 143 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are disclosed in the provided information.
22-01-2026
NWPX Infrastructure, Inc. disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0001437749-26-001761, Size: 254 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided.
22-01-2026
8-K filing dated January 22, 2026 (AccNo: 0001091667-26-000006, size 919 KB) discloses an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change from US SEC source. No specific details on officer name, title, reason for change, internal/external status, or financial metrics provided in the summary.
22-01-2026
Deere & Co (DEERE) filed an 8-K on January 22, 2026 (AccNo: 0001104659-26-005771, size 184 KB), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officers, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
22-01-2026
Lulu's Fashion Lounge Holdings, Inc. filed an 8-K on January 22, 2026 (AccNo: 0001104659-26-005773, Size: 203 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
22-01-2026
Ventyx Biosciences, Inc. disclosed an Officer Change event via SEC Form 8-K filed on 2026-01-22 (AccNo: 0001193125-26-019453, Size: 175 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector not specified.
22-01-2026
U.S. GoldMining Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003243, Size: 250 KB) disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. No specific details such as the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, names of individuals, reasons for the change, or any financial metrics are explicitly stated. Sector is not specified.
22-01-2026
BNB PLUS CORP. filed a Form 8-K on 2026-01-22 (AccNo: 0001104659-26-005784, Size: 184 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are provided in the summary. Sector is not specified.
22-01-2026
Fidelity National Information Services, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001136893-26-000003, Size: 271 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on affected positions, individuals, reasons, or quantitative data are provided. Sector is not specified.
22-01-2026
UNITED THERAPEUTICS Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005810, Size: 511 KB), disclosing an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary.
22-01-2026
Radian Group Inc disclosed an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0001193125-26-019508, size 136 KB). The filing references Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or quantitative data are provided in the available summary.
22-01-2026
CVR Partners, LP filed a Form 8-K on January 22, 2026 (AccNo: 0001425292-26-000005, Size: 135 KB), disclosing an Item 5.02 event regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are stated in the provided filing summary. Sector is not specified.
22-01-2026
JPMorgan Chase & Co. filed a Form 8-K on January 22, 2026 (AccNo: 0000019617-26-000052, Size: 287 KB), disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. No specific details on the affected officer(s), position(s), appointment or resignation status, reasons, or any quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
22-01-2026
Alight, Inc. (Delaware) filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003111, Size: 147 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment vs. resignation, reasons, or timing are provided. Event Type: Officer Change; Sector: not specified.
22-01-2026
LGL GROUP INC reported an Officer Change event via Form 8-K filed on January 22, 2026 (AccNo: 0001437749-26-001772, Size: 197 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons, or outcomes are disclosed in the provided information. Sector is not specified.
22-01-2026
AMC Networks Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001514991-26-000003, Size: 141 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
22-01-2026
H&R Block Inc reported an officer change via Form 8-K filed on January 22, 2026 (AccNo: 0000012659-26-000003, Size: 156 KB), under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details on the officer, position, reason, or terms are provided in the available summary.
22-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003113), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons for change, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
22-01-2026
Predictive Oncology Inc. filed a Form 8-K on 2026-01-22 (AccNo: 0001171843-26-000387, Size: 184 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific positions, names, reasons, or quantitative details provided.
22-01-2026
CORPAY, INC. filed an 8-K on 2026-01-22 (AccNo: 0001175454-26-000002, Size: 163 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, appointment/departure status, or reasons provided in the summary.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings